European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai

by | Jul 26, 2024 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating another hurdle for the companies as …

FEATURED

Flappy Bird Creator Reacts To The Return Of His Game

Dong Nguyen breaks his silence about the upcoming rerelease of Flappy Bird and says he has nothing to do with the new game. Comebacks in gaming are nothing new in the industry, but last week's announcement about the return of Flappy Bird caught some people by...

read more